Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Advisory

Abacus Health Products Announces Release Date for 2020 First Quarter Financial Results


Abacus Health Products, Inc. (CSE: ABCS, OTCQB: ABAHF) ("Abacus" or the "Company") announces that it will release its 2020 first quarter financial results on Thursday, May 28, 2020, prior to the market open.

The Company will not be hosting a conference call to discuss the results. The Company intends to hold the previously-announced special shareholders meeting ("Meeting") on Thursday, June 4, 2020 at 10:00 a.m. (EDT) to consider and vote upon its proposed acquisition by Charlotte's Web Holdings, Inc.

Further details on the Meeting and the proposed transaction can be found in the management information circular of Abacus dated May 4, 2020, available on its website at www.abacushp.com and under its profile on SEDAR at www.sedar.com.

About Abacus Health Products, Inc.

Abacus is principally engaged in the development and commercialization of over-the-counter (OTC) topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from the Cannabis sativa L plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus' formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers three lines of products: CBD CLINICtm, marketed to the professional practitioner market, and CBDMEDICtm and Harmony Hemptm, marketed to the consumer market. Abacus' products are offered across the United States and are produced by contract manufacturers, including in an FDA registered and audited manufacturing facility.

To learn more about Abacus, visit www.abacushp.com


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:48
Carrieverse Co., Ltd. has announced the grand opening of its Web3 metaverse game, 'Carrieverse', on the 28th of this month. It will be released in most regions around the world, and is expected to attract more than 1.2 million pre-registered users,...

at 20:45
The "Austria Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs on Social Commerce Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics - Q1 2024 Update" report has been added...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 20:30
The "Argentina Conversational Commerce Market Intelligence and Future Growth Dynamics Databook - 75+ KPIs on Conversational Commerce Trends by End-Use Sectors, Operational KPIs, Product Offering, and Spend By Application - Q2 2023 Update" report has...

at 20:15
The "Brazil Conversational Commerce Market Intelligence and Future Growth Dynamics Databook - 75+ KPIs on Conversational Commerce Trends by End-Use Sectors, Operational KPIs, Product Offering, and Spend By Application - Q2 2023 Update" report has...



News published on and distributed by: